Exelixis
EXEL
#1656
Rank
ยฃ9.85 B
Marketcap
ยฃ39.22
Share price
-1.01%
Change (1 day)
30.52%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company